General
What is Cannabinoid?
Answer
Cannabinoids are a diverse class of chemical compounds that naturally occur in the Cannabis sativa plant, as well as in the human body and other organisms. These molecules interact with the body's endocannabinoid system (ECS), a complex network of receptors that regulate various physiological processes including mood, pain sensation, appetite, and memory.
There are over 100 identified cannabinoids in cannabis, with the most well-known being tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary psychoactive compound responsible for cannabis's intoxicating effects, typically ranging from 15-30% in modern cannabis flower. CBD, conversely, is non-psychoactive and has gained significant attention for its potential therapeutic properties.
Cannabinoids are classified into three main categories: phytocannabinoids (plant-derived), endocannabinoids (naturally produced by the human body), and synthetic cannabinoids (artificially created in laboratories). Major phytocannabinoids include cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC), and tetrahydrocannabivarin (THCV), each with unique properties and potential effects.
The global cannabinoid market has experienced explosive growth, with the legal cannabis market valued at approximately $31.12 billion in 2022 and projected to reach $57.18 billion by 2030. This expansion has driven extensive research into minor cannabinoids, leading to the development of specialized extraction methods and isolation techniques.
Cannabinoids work by binding to CB1 and CB2 receptors throughout the body. CB1 receptors are primarily located in the brain and central nervous system, while CB2 receptors are found in immune cells and peripheral tissues. This interaction can influence neurotransmitter release and cellular signaling pathways.
The pharmaceutical industry has recognized cannabinoids' potential, with FDA-approved medications like Epidiolex (CBD-based) for epilepsy treatment. However, research remains limited due to federal regulations, and consumers should consult healthcare professionals before using cannabinoid products for therapeutic purposes.